Non-BLA Skin Substitute Wastage Payment Change
Summary: APMA alerts members: Effective January 1, 2026, CMS will not reimburse wastage for non-BLA skin substitutes; only administered units billable (JW/JZ modifiers not applicable). BLA products exempt. Providers must select appropriate product sizes to avoid waste; impacts DFU/VLU treatment planning and inventory.
Key Highlights:
- Effective: Jan 1, 2026.
- Scope: Non-BLA substitutes; no wastage payment.
- Exception: BLA products.
- Advice: Optimize sizing; review inventory.
Keywords: CMS wastage, non-BLA, skin substitutes, 2026, APMA